Exiscientia to raise $100 million in a series C deal backed by BlackRock

Biotech Health services Pharma Software Services

Investments

03 March 2021

Exiscientia (company)

Biotech Health services Pharma Software Services

Total investments received (USD): 203.88m

Round value (USD): 100m

Round investors: BlackRock Bristol-Myers Squibb Novo A/S Evotec AG GT Healthcare Capital

Industry: Biotech Health services Pharma Software Services

Health services Mobile Software Services

Investments 29 July 2021

AI (big data) Competitive Intelligence Health services Software Services

Investments 10 May 2021

Biotech Electronics Health services Manufacturing

Investments 04 May 2021